ArticleRheumatology and immunology research2022
Effectiveness of SB4 Transition from Originator Etanercept in Rheumatoid Arthritis and Axial Spondyloarthritis: A Subgroup Analysis from the BENEFIT Study.
Nicoletta Luciano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.